ImmuCell Corporation (ICCC)
NASDAQ: ICCC · Real-Time Price · USD
10.26
+0.02 (0.20%)
At close: Oct 27, 2026, 4:00 PM EDT
10.42
+0.15 (1.51%)
After-hours: Oct 27, 2026, 7:30 PM EDT
ImmuCell Employees
ImmuCell had 73 employees as of December 31, 2025. The number of employees decreased by 2 or 2.67% compared to the previous year. That makes ImmuCell the 33,176th largest employer in the world and 4,359th in the United States.
Employees
73
Change (1Y)
-2
Growth (1Y)
-2.67%
Revenue / Employee
$420,213
Profits / Employee
$10,786
Market Cap
93.18M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Tonix Pharmaceuticals Holding | 142 |
| Inovio Pharmaceuticals | 112 |
| PMV Pharmaceuticals | 54 |
| Milestone Pharmaceuticals | 38 |
| Genelux | 26 |
| NeurAxis | 24 |
| Tenax Therapeutics | 16 |
| Coya Therapeutics | 8 |
ICCC News
- 15 days ago - Immucell reports preliminary Q3 revenue $8M - TheFly
- 15 days ago - ImmuCell Announces a 46% Increase in Product Sales in Quarter Three of 2026, Based on Preliminary, Unaudited Sales Results - GlobeNewsWire
- 2 months ago - ImmuCell Earnings Call Transcript: Q2 2026 - Transcripts
- 2 months ago - ImmuCell Earnings release: Q2 2026 - Filings
- 2 months ago - ImmuCell Quarterly report: Q2 2026 - Filings
- 2 months ago - ImmuCell Slides: Q2 2026 - Filings
- 2 months ago - ImmuCell Announces Unaudited Financial Results for the Quarter Ended June 30, 2026 - GlobeNewsWire
- 2 months ago - ImmuCell Slides: Investor presentation - Filings